Aurinia Pharmaceuticals Statistics
NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.01+0.32 (+2.04%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 16.01 0.00%
Aurinia Pharmaceuticals by the numbers
Aurinia Pharmaceuticals has a market capitalization of $2.13 billion based on 133.05M shares outstanding. Its trailing P/E ratio is 7.0, and its forward P/E is 15.0. The stock trades 0.0% above its 50-day average and 2.9% above its 200-day average.
Average daily trading volume is 1.01M shares, or about $16.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AUPH valuation vs. peer median
| Metric | AUPH | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.13B | $2.03B | +5% |
| Avg. volume | 1.01M | 1.36M | -26% |
Peer median across 8 companies: VRDN, SDGR, PRGO, VERA, URGN, LKFT, MLYS, PHVS.
Valuation
- Market cap
- $2.13B
- P/E (TTM)
- 7.02
- Forward P/E
- 15.01
- EPS (TTM)
- $2.28
- Shares outstanding
- 133.05M
Price and trading
- Previous close
- 15.69
- Open
- 15.56
- Day range
- 15.50 – 16.15
- 52-week range
- 10.90 – 19.25
- 52-week change
- +36.72%
- Beta
- —
- Volume
- 682.53K
- Average volume
- 1.01M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 2.13B
- Pe
- 7.02
- Forward Pe
- 15.01
- Eps
- 2.28
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.25
- Week52 Low
- 10.90
- Avg Volume
- 1.01M
- Shares Outstanding
- 133.05M
- Ma50
- 16.01
- Ma200
- 15.56
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -16.83%
- Pct From52w Low
- 46.85%